Name: Supreme Court Rejects Challenge to Abortion Drug Mifepristone
Uploaded: 2024-06-16T16:40:37.000Z
Description: The Supreme Court unanimously rejected a challenge on June 13 that was brought by a doctors' group against the Food and Drug Administration's (FDA's) loosening of regulations of the abortion pill mifepristone, handing a win to the agency.

Sam Wang is a Washington correspondent for NTD News based in Washington, D.C. Sam covers politics on Capitol Hill, and U.S.-China relations. 

Sam Wang

NTD Plus

News

News with integrity, from the U.S. and around the world. Focused reports and analyses that shed light on major issues the world deserves to know. NTD Evening News airs daily at 6 p.m. ET.

NTD Evening News

Citizens Honor Police for Their Service and Sacrifice

Cary Dunst is the news anchor for NTD Evening News. He is also the co-host of NTD Good Morning.


Cary Dunst

Trump ‘Projecting American Influence and Leadership’ on Iran Issue in Beijing: China Expert

Chris Bob is a reporter for NTD and a host of "Profiles of Service." He is also a small business owner. Chris graduated from Union College with a concentration in politics and religion in Russia and the former Soviet Union.

Chris Bob

Senate Panel Advances Crypto Regulation Bill

Jason Blair is a national correspondent for NTD News based in California. 

Jason Blair

Lawmakers Weigh ‘Sanctuary’ Polices After Woman’s Death in Virginia

Christina Corona is a California-based reporter for NTD News. She primarily covers California news, politics, and entertainment.  

Christina Corona

Bonta Announces Major Fentanyl Bust in California

Arian Pasdar is an international correspondent for NTD News based in South America. His reporting focuses on immigration and key events in Latin America.

Arian Pasdar

CENTCOM Commander Admiral Cooper Praises Trump's Military Actions

David Lam is a national correspondent based in California and a part-time anchor for "NTD Tonight." Before joining NTD he was a financial analyst.

David Lam

Lawyers in OpenAI Trial Give Closing Arguments

Eva Fu is a New York-based writer for The Epoch Times focusing on U.S. politics, U.S.-China relations, religious freedom, and human rights. Contact Eva at eva.fu@epochtimes.com

Eva Fu

Jack Bradley is a Washington correspondent for NTD News based in Washington, D.C. Jack previously anchored "NTD Newsroom" and worked as an assistant producer for the show. 

Jack Bradley

China News

Organ Harvesting in China

Congressional Hearing Spotlights Forced Organ Harvesting in China

Dave Martin is NTD's Senior Sports Reporter and sports analyst. He also hosts "Data Hub" segments during NTD's special election coverage, "The Nation Decides."

Dave Martin

Report: Giants WR Nabers Had 2nd Procedure on Knee

Xavier Becerra Leads New California Governor Poll

NTD Evening News Full Broadcast (May 15)

NTD Evening News Full Broadcast (May 14)

NTD Evening News Full Broadcast (May 13)

NTD Evening News Full Broadcast (May 12)

NTD Evening News Full Broadcast (May 11)

Don Ma is an anchor and senior business correspondent based at the network's global headquarters in New York City. Don is the anchor and producer of NTD's "Business Matters," which airs weekdays at 4:30 pm ET.

Don Ma

NTD Evening News Full Broadcast (May 10)

Arleen Richards is NTD's legal correspondent based at the network's global headquarters in New York City, where she covers all major legal stories. Arleen holds a Doctor of Law (J.D.).


Arleen Richards

NTD Evening News Full Broadcast (May 9)

NTD Evening News Full Broadcast (May 8)

NTD Evening News Full Broadcast (May 7)

NTD Evening News Full Broadcast (May 6)

NTD Newsroom comprises teams of reporters, editors, and producers assigned to cover breaking news and other stories.


NTD Newsroom

Fast, compelling, first-hand news from China. China in Focus airs Monday–Friday at 8 p.m. ET.

China in Focus

China Sends Warships to Pacific Drill as Tensions With Japan Rise

Reuters is a news agency owned by Thomson Reuters. It employs around 2,500 journalists and 600 photojournalists in about 200 locations worldwide writing in 16 languages.

Reuters

We present news that is truthful and based on facts, outside of the political fog. Instead of focusing on the negative things happening around us, our mission is to give our viewers a good morning with empathetic and uplifting stories. Our aim is to provide an antidote to negativity by shining a light on the best side of people. We speak to inspiring people who positively impact communities, pursue topics that represent our common human values, and will never miss an opportunity to bring you heartwarming stories.

NTD Good Morning

2 US Embassy Personnel Assigned to Cartel Case Killed in Car Accident

The Associated Press is an American not-for-profit news agency headquartered in New York City. 

The Associated Press

US News

Gunman Kills 8 Children, Including 7 of His Own, in Louisiana Mass Shooting

Flora Hua is a reporter based at NTD's global headquarters in New York City, where she covers China news, U.S.-China relations, and human rights issues. Flora primarily contributes to NTD's "China in Focus."  

Flora Hua

Trump: Seized Iranian Ship May Have ‘A Gift From China’

Joseph Lord is a congressional reporter for The Epoch Times.


Joseph Lord

Aldgra Fredly is a freelance writer covering U.S. and Asia Pacific news for The Epoch Times.

Aldgra Fredly

Former NYC Mayor Rudy Giuliani Hospitalized in Critical Condition: Spokesman

Wildfires Across Georgia and Florida Have Destroyed Nearly 50 Homes and Are Forcing Evacuations

News you can trust from the U.S. and around the world. Critical information and insight. We cover the stories that others don’t. NTD News Today airs Monday–Friday at 11 a.m. ET.

NTD News Today

US Warns of China Hacks via Routers, Smart Devices

Juliet Song is an international correspondent exclusively covering China news for NTD. She primarily contributes to NTD's "China in Focus," covering U.S.-China relations, the Chinese regime's human rights abuses, and domestic unrest inside China.

Juliet Song

2 Americans Among Suspected Communist Rebels Killed in Clashes With Troops, Philippine Officials Say

Ryan Morgan is a reporter for The Epoch Times focusing on military and foreign affairs. He was previously a news writer for NTD. 


Ryan Morgan

Mari Otsu is NTD's White House correspondent based in Washington. 

Mari Otsu

World News

Middle East

Iran

3 US Warships Fend Off Iranian Attacks, Trump Says Ceasefire Still Holds

Health News

3 Dead in Suspected Hantavirus Outbreak on Cruise Ship in Atlantic Ocean: WHO

The Supreme Court unanimously rejected a challenge on June 13 that was brought by a doctors' group against the Food and Drug Administration's (FDA's) loosening of regulations of the abortion pill mifepristone, handing a win to the agency.

The court held that those challenging the status of the pill lacked the legal standing to do so.

The decision came two years after the court’s landmark 2022 ruling in Dobbs v. Jackson Women’s Health Organization, which overturned Roe v. Wade and returned the regulation of abortion to the states.

President Joe Biden quickly hailed the new decision, describing mifepristone as “safe and effective.”

He also criticized Republicans, saying their “attacks on medication abortion are part of … [an] extreme and dangerous agenda to ban abortion nationwide.”

Since Roe v. Wade was reversed, “Republican elected officials have imposed extreme abortion bans in 21 states, some of which include zero exceptions for rape or incest,” the president said in a written statement.

The 9–0 <a href="https://www.supremecourt.gov/opinions/23pdf/23-235_n7ip.pdf" target="_blank" rel="nofollow noopener">opinion</a> was written by Justice Brett Kavanaugh. Justice Clarence Thomas filed a concurring opinion.

Medication abortions are reportedly lawful in 36 states and the District of Columbia.

A medication abortion generally involves the use of mifepristone, which blocks progesterone, a hormone, and misoprostol, which induces contractions. Misoprostol, which is widely available because it has many medical uses, wasn't an issue in the current litigation. Also known as mifeprex and RU-486, mifepristone is made by Danco Laboratories.

Advocates for mifepristone said the current system by which the drug is provided is safe, while opponents said it puts women at risk by ignoring safety measures that used to be in place.

The Biden administration and pro-abortion groups warned that the Supreme Court’s eventual decision in the case could affect the drug’s availability.

The case is actually two appeals that the court consolidated—Food and Drug Administration v. Alliance for Hippocratic Medicine (AHM) and Danco Laboratories LLC v. AHM.

The Supreme Court case came after Judge Matthew Kacsmaryk of the U.S. District Court for the Northern District of Texas, an appointee of President Donald Trump, held in April 2023 that the FDA was wrong to approve mifepristone for public use in 2000. He said the FDA was under political pressure to get the pill on the market and then, after that, had deliberately dragged out judicial review of the drug for years.

Judge Kacsmaryk found the FDA had improperly lifted restrictions related to accessing the drug and issued a preliminary nationwide injunction retroactively staying the FDA’s approval.

In 2016, the FDA changed the drug’s official label, extending the cutoff for use from 49 days of gestation to 70 days. At the same time, the agency allowed the drug to be prescribed with only one in-person visit and halted the requirement that prescribers report nonfatal adverse events.

In 2021, the agency allowed patients to receive the drug by mail instead of having to pick it up in person from a specially certified health care provider.

The U.S. Court of Appeals for the Fifth Circuit refused to block most of Judge Kacsmaryk's ruling, holding that the FDA’s actions in 2016 and 2021 were probably unlawful. The Supreme Court blocked the injunction over the original approval of the drug, allowing mifepristone to remain on the market, but pointedly refused to agree to commit to examining whether the original approval of the drug in 2000 was lawful.
<h2>Issues of Standing</h2>
During oral arguments at the Supreme Court on March 26, much of the discussion focused on legal standing, that is, the connection a litigant has to a controversy before the court.

U.S. Solicitor General Elizabeth Prelogar told the justices that the Alliance for Hippocratic Medicine, whose member groups include physicians, lacked standing to challenge FDA regulations.

The agency has found the abortion pill to be “safe and effective” across five presidential administrations “and millions of Americans have used mifepristone to safely end their pregnancies.”

The other side “may not agree with that choice, but that doesn’t give them Article III standing or a legal basis to upend the regulatory scheme,” she said. Article III of the U.S. Constitution governs federal courts.

In the court’s opinion, Justice Kavanaugh recounted that several pro-life physicians and associations sued the FDA, arguing that the agency’s actions ran afoul of the federal Administrative Procedure Act.

"But the plaintiffs do not prescribe or use mifepristone. And FDA is not requiring them to do or refrain from doing anything. Rather, the plaintiffs want FDA to make mifepristone more difficult for other doctors to prescribe and for pregnant women to obtain," Justice Kavanaugh wrote.

"Under Article III of the Constitution, a plaintiff's desire to make a drug less available for others does not establish standing to sue. Nor do the plaintiffs' other standing theories suffice. Therefore, the plaintiffs lack standing to challenge FDA's actions."

Redress is available to the plaintiffs who challenge the FDA’s decision, but it is to be found in the policymaking process.

Although the challengers "have sincere legal, moral, ideological, and policy objections to elective abortion and to FDA's relaxed regulation of mifepristone," Justice Kavanaugh wrote, under the Constitution "those kinds of objections alone do not establish a justiciable case or controversy in federal court."

If a question is justiciable, it means that it can be assessed according to legal principles by a court.

The challengers did not show that the FDA's "relaxed regulatory requirements likely would cause them to suffer an injury in fact," Justice Kavanaugh wrote, and this means "the federal courts are the wrong forum for addressing the plaintiffs' concerns about FDA's actions."

Instead, the challengers may bring their concerns to the president and the FDA through the regulatory process or the legislative process, or to their fellow citizens.

The Supreme Court reversed the ruling of the Fifth Circuit and remanded the case to that court "for further proceedings consistent with this opinion."
<h2>Plaintiffs Respond</h2>
At a news conference following the release of the opinion, Erin Hawley, senior counsel at the Alliance Defending Freedom (ADF), which represented the Alliance for Hippocratic Medicine, said she was disappointed by the ruling.

"The FDA's own label says that roughly one in 25 women who take this drug will end up in the emergency room and up to 7 percent will require surgery. Data cited by the FDA shows that hospitalizations increase about 300 percent with no in-person doctor visit," she said.

"ADF and our clients will continue to advocate for women's health and seek to restore common sense safeguards for abortion drugs. We're hopeful that the FDA will be held to account for putting politics above women's health."

Dr. Ingrid Skop, vice president of the Charlotte Lozier Institute, is a practicing obstetrician-gynecologist with more than 30 years of experience.

"I have seen firsthand that mail-order abortion drugs harm my patients, both mothers and their unborn children," Dr. Skop said in a written statement, criticizing that in-person doctor visits aren't required.

"As a tragic result, I expect to see more women need blood transfusions, emergency surgery, and other drastic measures, and our emergency medical systems overwhelmed."

<em>From <a href="https://www.theepochtimes.com/us/supreme-court-rejects-challenge-to-abortion-drug-mifepristone-5659430">The Epoch Times</a></em>

Latest

Court

Drug

abortion

Videos

Breaking News

04_Top Stories

Premium Picks

Latest Clips

Management

Supreme Court

Matthew Vadum is an award-winning investigative journalist.

Matthew Vadum

mifepristone

Courts

Latest and breaking news, documentaries, movies, and lifestyle content on NTD+.
 
Empower your knowledge and elevate your spirit with NTD+, your go-to destination for truthful news, insightful documentaries, and captivating lifestyle content that enriches your life.